MYPAID CAPSULES

Država: Južnoafrička Republika

Jezik: engleski

Izvor: South African Health Products Regulatory Authority (SAHPRA)

Dostupno od:

Adcock Ingram Limited

Doziranje:

See ingredients

Farmaceutski oblik:

CAPSULES

Sastav:

EACH CAPSULE CONTAINS IBUPROFEN 200,0 mg PARACETAMOL 250,0 mg

Status autorizacije:

Registered

Datum autorizacije:

1994-10-04

Uputa o lijeku

03/01/2022
M.M.
Page
1
of
9
PATIENT INFORMATION LEAFLET
SCHEDULING STATUS S2
MYPAID, EACH CAPSULE CONTAINS:
IBUPROFEN 200 MG PARACETAMOL 250 MG SUGAR FREE
READ ALL OF THIS LEAFLET CAREFULLY BECAUSE IT CONTAINS IMPORTANT
INFORMATION FOR YOU.
MYPAID is available without a doctor’s prescription, for you to
treat a mild illness.
Nevertheless, you still need to use MYPAID carefully to get the best
results from it.

Keep this leaflet. You may need to read it again.

Do not share MYPAID with any other person.

Ask your health care provider or pharmacist if you need more
information or advice.

You must see a doctor if your symptoms worsen or do not improve after
10 days.
1.WHAT MYPAID IS AND WHAT IT IS USED FOR
MYPAID contains ibuprofen and paracetamol which belongs to a group of
medicine referred
to as non-steroidal anti-inflammatory medicines (NSAIDs).
MYPAID is used for the relief of mild to moderate pain associated with
inflammation and fever
including:

Headache

Muscular aches and pain
03/01/2022
M.M.
Page
2
of
9

Menstrual pain

Dental pain
2. WHAT YOU NEED TO KNOW BEFORE YOU TAKE MYPAID
DO NOT TAKE MYPAID

If you are allergic to ibuprofen or paracetamol or any of the other
ingredients of
MYPAID tablets (listed in section 6.1).

If you have asthma or bronchospasm (difficulty breathing)

If you have bleeding disorder.

If you have renal failure

If you have heart disease.

If you have severe liver function impairment and in those who are
receiving coumarin
anticoagulants.

If you have peptic ulceration or a history of such ulceration.

If you are pregnant, do not use MYPAID at 20 weeks or later in your
pregnancy
unless specifically advised to do so by your health care professional
because these
medicines may cause problems in your unborn baby.

If you are younger than 12 years old.
03/01/2022
M.M.
Page
3
of
9
WARNINGS AND PRECAUTIONS
Special care should be taken with MYPAID:

Tell your doctor or health care provider if you are pregnant or plan
to become
pregn

Svojstava lijeka

03/01/2022
M.M.
Page
1
of
12
PROFESSIONAL INFORMATION FOR MEDICINES FOR HUMAN USE
SCHEDULING STATUS:
1. NAME OF MEDICINE
MYPAID
STRENGTH
Each capsule contains:
Ibuprofen 200 mg
Paracetamol 250 mg
PHARMACEUTICAL FORM
Capsule
2. QUALITATIVE AND QUANTITATIVE COMPOSITION
Each capsule contains:
Ibuprofen
200 mg
Paracetamol 250 mg
Sugar free
3. PHARMACEUTICAL FORM
Green and white, hard gelatin capsule, with R25 imprinted on cap and
body; containing
white, granular powder.
S2
03/01/2022
M.M.
Page
2
of
12
4. CLINICAL PARTICULARS
4.1. THERAPEUTIC INDICATIONS:
MYPAID capsule are indicated for the relief of headache from
Musculo-skeletal origin,
feverishness, muscular, menstrual and dental pain.
4.2. POSOLOGY AND METHOD OF ADMINISTRATION
Not recommended for children under twelve years.
Adults and children over 12 years: Two capsules every four hours, but
not more than six
capsules in twenty-four hours. Capsules are to be taken with food or
after meals with
sufficient water.
Consult your doctor if no relief is obtained with the recommended
dosage.
Use the lowest effective dose for the shortest possible duration of
treatment.
4.3. CONTRAINDICATIONS:
MYPAID not recommended for use by pregnant or breast-feeding women. It
should not be
given to patients with asthma or bronchospasm, bleeding disorders,
cardiovascular disease,
peptic ulceration or a history of such ulceration, renal failure,
severe liver function
impairment and in those who are receiving coumarin anticoagulants.
Patients who are sensitive to any ingredients or aspirin should not be
given MYPAID.
Avoid use of NSAIDs in women around 30 weeks gestation and later in
pregnancy due to the
risks of oligohydramnios/ foetal renal dysfunction and premature
closure of the foetal ductus
arteriosus.
03/01/2022
M.M.
Page
3
of
12
4.4. SPECIAL WARNINGS AND PRECAUTIONS FOR USE:
THIS PRODUCT CONTAINS PARACETAMOL WHICH MAY BE FATAL IN OVERDOSE. IN
THE EVENT OF
OVERDOSAGE OR SUSPECTED OVERDOSE AND NOTWITHSTANDING THE FACT THAT THE
PERSON MAY
BE DOCTOR, HOSPITAL OR POISON CENTRE MUST